Pancreatic Cancer Research

ResearcherBC Cancer AgencyNo recent work listed

Hagen Fritz Kennecke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3211-0656; OpenAlex author ID A5053138163. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 4

  1. Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer. Last author DOI 10.1097/coc.0000000000000500↗
  2. Defining Eligibility of FOLFIRINOX for First-Line Metastatic Pancreatic Adenocarcinoma (MPC) in the Province of British Columbia: A Population-based Retrospect… First author DOI 10.1097/coc.0000000000000205↗
  3. nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial. Co-author DOI 10.1007/s12325-016-0327-4↗
  4. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. Last author DOI 10.1002/cam4.459↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel John Renouf · 3 shared papers, 2015–2019 · strength 0.24
  2. Winson Y. Cheung · 2 shared papers, 2017–2019 · strength 0.18
  3. Sharlene Gill · 2 shared papers, 2017–2019 · strength 0.18
  4. Hui‐Li Wong · 1 shared paper, 2019 · strength 0.10
  5. Erica S. Tsang · 1 shared paper, 2019 · strength 0.10
  6. Maria Yi Ho · 1 shared paper, 2017 · strength 0.08
  7. Renata D’Alpino Peixoto · 1 shared paper, 2015 · strength 0.06
  8. David F. Schaeffer · 1 shared paper, 2015 · strength 0.06
  9. Alfredo Romano · 1 shared paper, 2016 · strength 0.06
  10. Mustapha Ali Tehfe · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.